<code id='242F8F31FC'></code><style id='242F8F31FC'></style>
    • <acronym id='242F8F31FC'></acronym>
      <center id='242F8F31FC'><center id='242F8F31FC'><tfoot id='242F8F31FC'></tfoot></center><abbr id='242F8F31FC'><dir id='242F8F31FC'><tfoot id='242F8F31FC'></tfoot><noframes id='242F8F31FC'>

    • <optgroup id='242F8F31FC'><strike id='242F8F31FC'><sup id='242F8F31FC'></sup></strike><code id='242F8F31FC'></code></optgroup>
        1. <b id='242F8F31FC'><label id='242F8F31FC'><select id='242F8F31FC'><dt id='242F8F31FC'><span id='242F8F31FC'></span></dt></select></label></b><u id='242F8F31FC'></u>
          <i id='242F8F31FC'><strike id='242F8F31FC'><tt id='242F8F31FC'><pre id='242F8F31FC'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:93229
          Paul Berggreen, a gastroenterologist at Arizona Digestive Health who formed a new lobbying group for independent physician practices. Arizona Digestive Health/ GI Alliance

          Private equity gets a bad rap in health care. But some doctors see that kind of cash and consolidation as the only way for their practices to survive — and now, they’re taking that message to Washington.

          Lower pay, difficult negotiations with insurance companies, regulatory requirements from both government and commercial payers, expensive and inefficient IT systems, and the challenge of competing against hospital systems have created a “cascade of problems that seem like they are almost insurmountable” for independent practices, said Paul Berggreen, a gastroenterologist at Arizona Digestive Health.

          advertisement

          Berggreen is joining with other doctors to start a lobbying group for private practices, the brand-new American Independent Medical Practice Association, or AIMPA, to fight against those problems and advocate for private practice physicians.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Why is France rioting? What to know about the fatal police shooting of Nahel M
          Why is France rioting? What to know about the fatal police shooting of Nahel M

          1:17FrenchpoliceofficerspatrolinfrontoftheArcdeTriompheintheChampsElyseesareaofParis,France,onJuly1,

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Duchenne patients, backed by ‘dark money’ group, to debate drug prices

          ICERPresidentStevenD.PearsonCraigF.Walker/TheBostonGlobeMeetingsoftheInstituteforClinicalandEconomic